ANDA 61653, held by Bristol. Tetracycline Phosphate Complex.
As of Nov 15, 2026, ANDA 61653 (Tetrex), held by Bristol, was first approved by FDA on Jun 20, 1972, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 20, 1972 | Original application | Approved | None posted |
| TetrexEQ 100MG HYDROCHLORIDE · capsule;oral | Tetracycline Phosphate Complex | Discontinued |
| TetrexEQ 250MG HYDROCHLORIDE · capsule;oral | Tetracycline Phosphate Complex | Discontinued |
| TetrexEQ 500MG HYDROCHLORIDE · capsule;oral | Tetracycline Phosphate Complex | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters